含酶含片控制牙菌斑的功效与安全性:随机对照预试验
一项双臂平行随机对照预试验纳入24名健康成人,分为含酶含片组与安慰剂组各12人,每日含服3次、连续7天并禁止口腔卫生措施。结果显示含酶含片在第1天显著降低新形成菌斑(TM-QHPI,p=0.012),7天时组间无显著差异(p=0.37),牙龈指数无组间差异(p=0.62),唾液菌群丰富度增幅组间有统计学差异(p=0.0495),全程无不良事件。
要点
- 含酶含片可能减少第1天新形成菌斑,7天时效果不显著。
- 7天试验区未出现牙龈指数升高,组间无差异。
- 可作为机械性菌斑控制的辅助手段,非杀菌性思路。
核心结论
- 含多种酶的含片可减少1天后的新形成菌斑,并减缓唾液中菌种增加的过程。
- 含片可能作为常规机械性去除菌斑的辅助手段。
研究设计与样本
- 随机对照预试验,两个平行组,24名健康成人,含酶含片组12例、安慰剂组12例。
- 每日含服1片、3次/天,连续7天,期间不允许口腔卫生措施。
- 用TM-QHPI评估新形成菌斑,用牙龈指数(GI)评估牙龈炎,并用16S rRNA基因测序分析菌斑与唾液样本。
主要发现
- 干预1天后,含酶含片组平均TM-QHPI较基线显著低于安慰剂组(p=0.012)。
- 干预7天后,两组平均TM-QHPI值无显著差异(p=0.37)。
- 干预期间GI值未升高,两组间无差异(p=0.62)。
- 7天无口腔卫生期间菌斑和唾液样本的细菌丰富度均增加,唾液样本组间差异有统计学意义(p=0.0495)。
- 所有受试者均完成研究,未报告不良事件。
临床怎么用
- 可考虑将含酶含片作为机械性菌斑去除的辅助措施,但证据来自小样本预试验。
- 对含酶含片的效果评价应关注短期(如1天)菌斑控制,不宜外推为7天持续优势。
局限性
- 为预试验,样本量小(共24例),结论需更大规模试验验证。
- 7天禁止口腔卫生的实验条件与日常临床情境存在差异。
- 观察期短,未评估长期菌斑、牙龈炎及菌群安全性结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the effect of daily use of a multiple-enzyme lozenge on de novo plaque formation, on gingivitis development, and on the oral microbiome composition. METHODS: This trial with two parallel arms included 24 healthy adults allocated to the Active (n = 12) or Placebo (n = 12) group. Subjects consumed one lozenge three times daily for seven days, and no oral hygiene procedures were allowed. Differences in de novo plaque accumulation between a baseline period, and one and seven days of intervention were assessed by the Turesky-modification of the Quigley-and-Hein-Plaque-Index (TM-QHPI). The development of gingivitis after seven days of intervention was assessed by the Gingival Index (GI). Plaque and saliva samples were collected at baseline and after seven days of intervention, and evaluated by 16S rRNA gene sequencing. RESULTS: All subjects completed the study, and no adverse events were reported. After one day, the average TM-QHPI was significantly lower in the Active than in the Placebo group, as compared to baseline (p = 0.012). After 7 days, average TM-QHPI values did not differ significantly between groups (p = 0.37). GI values did not increase during the intervention period, with no difference between groups (p = 0.62). Bacterial richness increased in both plaque and saliva samples over a seven-day oral hygiene-free period, with a statistically significant difference for the saliva samples (p = 0.0495) between groups. CONCLUSIONS: A multiple-enzymes lozenge decreased the build-up of de novo plaque after one day and slowed down the process of species increment in saliva. The lozenge may be an adjunct to regular mechanical plaque removal. CLINICAL SIGNIFICANCE: Dental plaque is the main cause of caries, gingivitis, and periodontitis. The search for therapeutic adjuncts to mechanical plaque removal that have no harmful effects on the oral microbiome is important. Treatment with multiple plaque-matrix degrading enzymes is a promising non-biocidal approach to plaque control.
引用
- Schlafer S, Johnsen KK, Kjærbølling I, et al. The efficacy and safety of an enzyme-containing lozenge for dental biofilm control-a randomized controlled pilot trial. J Dent. 2024. PMID: 38830531. doi:10.1016/j.jdent.2024.105107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。